We are a not-for-profit organization of pharmaceutical and biotechnology companies with the mission of advancing science and technology to augment the capability of member companies to develop transformational solutions that benefit patients, regulators and the broader R&D community.
December 2019
IQ DILI is pleased to announce their latest publication in AP&T on detection, assessment and management best practices for suspected DILI in clinical trials for adults with cholestatic liver disease.
November 2019
The IQ MPS Affiliate has launched its new website. Open this story to learn more about the Affiliate and its activities.
2017-2019 IQ Consortium Drug Product Pediatric Working Group Public Webinar Series
December 31, 2019 - December 31, 2020